National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Loss, Grief, and Bereavement (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 05/22/2008



Purpose of This PDQ Summary






Overview






Model of Life-threatening Illness






The Dying Trajectory






Anticipatory Grief






Phases of Bereavement






General Aspects of Grief Therapy






Complicated Grief






Children and Grief






Cross-cultural Responses to Grief and Mourning






Get More Information From NCI






Changes to This Summary (05/22/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Complicated Grief

Complicated or pathological grief reactions are maladaptive extensions of normal bereavement. These maladaptive reactions overlap psychiatric disorders and require more complex, multimodal therapies than do uncomplicated grief reactions. Adjustment disorders (especially depressed and anxious mood or disturbance of emotions and conduct), major depression, substance abuse, and even posttraumatic stress disorder (PTSD) are some of the more common psychiatric sequelae of complicated bereavement. Grief that becomes pathologic is often identifiable by lingering symptomatology, increased disruption of psychosocial functioning caused by the symptoms, or the intensity of subsyndromal symptoms (e.g., intense suicidal thoughts or acts upon the loss).[1]

Complicated or unresolved grief can take many forms.[2,3] Complications may manifest as absent grief (i.e., grief and mourning processes are totally absent), inhibited grief (a lasting inhibition of many of the manifestations of normal grief), delayed grief, conflicted grief, or chronic grief. Risk factors for pathologic grief include suddenness of loss; gender of the bereaved; and the existence of an intense, overly close, or highly ambivalent relationship to the deceased. Pathologic grief reactions that extend to major depressive episodes should be treated with combined drug and psychotherapeutic interventions, though the efficacy of these combined approaches is untested. The bereaved who maintain long-standing avoidance of any and all reminders of the deceased, who re-experience the loss or the presence of the deceased in illusions or intrusive thoughts or dreams, and who startle and panic easily at reminders of the loss might be considered for a diagnosis of PTSD (even without meeting all the criteria for a psychiatric diagnosis).[4] Substance abuse in the bereaved is frequently an attempt at self-medication of painful feelings and symptoms (such as insomnia) and can be targeted for drug and psychotherapeutic intervention.

References

  1. Rando TA: Treatment of Complicated Mourning. Champaign: Research Press, 1993. 

  2. Rando TA: Grief, Dying, and Death: Clinical Interventions for Caregivers. Champaign: Research Press Company, 1984. 

  3. Raphael B: The Anatomy of Bereavement. New York: Basic Books, Inc., 1983. 

  4. Parkes CM, Relf M, Couldrick A: Counselling in Terminal Care and Bereavement. Baltimore: BPS Books, 1996. 

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov